Constarium
← Search

Data · dataset · 2026

Image 2_Serum free eicosapentaenoic acid-to-arachidonic acid ratio and long-term risk of major adverse cardiovascular events in patients with coronary artery disease.tiff

Listed in ZivaHub

Background<p>The eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio reflects the balance between n-3 and n-6 polyunsaturated fatty acids.

Description

We examined the association between the serum free (non-esterified) EPA/AA ratio and long-term major adverse cardiovascular events (MACE) in patients with angiographically confirmed coronary artery disease (CAD).</p>Methods<p>This single-center retrospective cohort study included 308 patients with CAD.

Serum free fatty acids were quantified by LC-MS/MS, and the free EPA/AA ratio was evaluated as the primary fatty-acid biomarker. Cox proportional hazards models were used to estimate hazard ratios (HRs), and principal component analysis (PCA) was used to explore fatty-acid patterns.</p>Results<p>During a median follow-up of 48.7 months, 201 first MACE events occurred. In the fully adjusted primary analysis, each 1-SD increase in the free EPA/AA ratio was associated with a lower risk of MACE (HR = 0.82, 95% CI 0.70–0.96, P = 0.011; FDR-adjusted P = 0.049).

Read the rest (1 more)

The association was attenuated after additional adjustment for analytical batch (HR = 0.92, 95% CI 0.77–1.10, P = 0.375) and in a Cox model stratified by batch (HR = 0.92, 95% CI 0.77–1.11, P = 0.398).</p>Conclusions<p>A higher serum free EPA/AA ratio was associated with a lower risk of MACE in the primary multivariable analysis, but the association was attenuated in additional sensitivity analyses. These findings should be interpreted cautiously and require validation in independent cohorts.</p>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Disease 75% · Image 75% · Longitudinal study 65% · Mass spectrometry 65%
Provenance · 1 source records, 12 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/340214916 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:diseaseenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].anzsrc:field:320101mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cardiology']
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[method].local:method:longitudinal-studyenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (65%)
concepts[modality].local:modality:imageenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:mass-spectrometryenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (65%)
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
licensesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/rights
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title